Wealth Enhancement Advisory Services, LLC Applied Therapeutics Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 14,775 shares of APLT stock, worth $5,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,775Holding current value
$5,910% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
131Shares Held
111MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$4.6 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$4 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$3.85 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$3.53 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$3.5 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $19.2M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...